))
What I Did Last Summer: Christianne Blais on corticosteroid research
Manage episode 300995904 series 2876289
コンテンツは Office of the Vice-Dean Research, College of Medicine, University of Saskatchewan., University of Saskatchewan, OVDR, and College of Medicine によって提供されます。エピソード、グラフィック、ポッドキャストの説明を含むすべてのポッドキャスト コンテンツは、Office of the Vice-Dean Research, College of Medicine, University of Saskatchewan., University of Saskatchewan, OVDR, and College of Medicine またはそのポッドキャスト プラットフォーム パートナーによって直接アップロードされ、提供されます。誰かがあなたの著作物をあなたの許可なく使用していると思われる場合は、ここで概説されているプロセスに従うことができますhttps://ja.player.fm/legal。
Taking a daily puffer with inhaled corticosteroids is a mainstay for millions of people who have eosinophilic asthma.
But doctors don't always know what dosage will be most effective for their patients, in preventing inflammation.
Up to now, studies of different corticosteroids have been hit and miss, with a patchwork of different approaches to brochoprovocation, subject groupings, and wash-out times. A study may prove a drug is safe, then neglects to accurately measure the dosage a patient needs.
Over the past few summers, Christianne Blais looked at what asthma patients need, to breathe easy.
“Our ultimate goal was to see the relative potency,” said Blais. “How do they measure up?”
The trouble is, the existing research was "kind of all over the map."In this episode, the fourth-year University of Saskatchewan medical student weighs in on what works, and what doesn't, in bronchoprovocations studies of corticosteroids in treating patients with eosinophilic asthma.
81 つのエピソード
シェア
